NMRD - Nemaura Medical - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

NMRD is currently covered by 2 analysts with an average price target of $2.49. This is a potential upside of $2.41 (3012.5%) from yesterday's end of day stock price of $0.08.

Nemaura Medical's activity chart (see below) currently has 1 price targets and 6 ratings on display. The stock rating distribution of NMRD is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for NMRD is $4, Lowest price target is $2.5, average price target is $2.49.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 21-Aug-2023. First documented stock forecast 03-Dec-2021.

Best performing analysts who are covering NMRD - Nemaura Medical:

Yi Chen Constantine Davides

Currently out of the existing stock ratings of NMRD, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

2.5

$2.4 (2400.00%)

7 months 7 days ago

0/3 (0%)

$1.74 (228.95%)

Buy

4

$3.9 (3900.00%)

7.5

8 months 11 days ago

0/2 (0%)

$3.08 (334.78%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NMRD (Nemaura Medical) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on NMRD (Nemaura Medical) with a proven track record?

YI CHEN

Which analyst has the current lower performing score on NMRD (Nemaura Medical) with a proven track record?

CONSTANTINE DAVIDES

Which analyst has the most public recommendations on NMRD (Nemaura Medical)?

Yi Chen has 24 price targets and 15 ratings on NMRD

Which analyst is the currently most bullish on NMRD (Nemaura Medical)?

Constantine Davides with highest potential upside - $3.9

Which analyst is the currently most reserved on NMRD (Nemaura Medical)?

Yi Chen with lowest potential downside - $2.4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?